Clinical Trial Update: A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating the intrathecal combination of rituximab and methotrexate for central nervous system lymphoma and intraocular lymphoma; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Intraocular Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Rituxan (rituximab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Central Nervous System Lymphoma, Intraocular Lymphoma | Phase 1 | Status: COMPLETED